Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Galway – page 8

104 clinical trials in Galway, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Galway at a glance
104
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

104 trials in Galway

Open in trial search

Study of Methylone Treatment for Adults with Post-Traumatic Stress Disorder (PTSD)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Methylone
  • Sponsor:Transcend Therapeutics Inc.

Hidradenitis

Not recruiting

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

COVID-19

Not recruiting

Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:University Of Minnesota

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Compass Pathfinder Limited

Dermatitis atopic

Not recruiting

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Safety and Effectiveness of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Incyte Corp.

Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:ETOP IBCSG Partners Foundation

Breast cancer

Not recruiting

Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Colitis ulcerative

Not recruiting

Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Lung disorder

Not recruiting

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF

Monkeypox

Not recruiting

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tecovirimat
  • Sponsor:University Of Oxford

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Galway

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on multiple myeloma, lung cancer, and various forms of breast cancer. Research includes novel therapeutic combinations and targeted treatments for both early-stage and metastatic conditions.

  • Lung Cancer Therapeutics
  • Multiple Myeloma Treatments
  • Breast Cancer Innovations

Investigating new treatment approaches using advanced targeted therapies and immunotherapy combinations.

02 Hematological Studies

Advanced research into blood-related cancers, particularly chronic lymphocytic leukemia and lymphoma. Studies evaluate novel drug combinations and treatment duration optimization.

  • CLL Treatment Protocols
  • B-Cell Lymphoma Therapies
  • Treatment Duration Studies

Focusing on personalized treatment approaches based on measurable residual disease monitoring.

03 Cardiovascular Research

Innovative studies addressing hypertension and cardiovascular health, including research on obesity-related cardiovascular conditions and new therapeutic approaches.

  • Resistant Hypertension
  • Coronary Artery Disease
  • Cardiovascular Risk Management

Exploring novel interventions for blood pressure control and atherosclerosis prevention.

04 Dermatology Studies

Clinical investigations focusing on chronic skin conditions, particularly atopic dermatitis and hidradenitis suppurativa, testing new therapeutic options.

  • Moderate to Severe Eczema
  • Inflammatory Skin Conditions
  • Combined Therapy Approaches

Evaluating advanced treatments for patients requiring systemic therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.